LabTools_CRISPR-phenotype-990x120 (2).png
If you have already registered, please check your email for the webinar link.

Event Overview

CRISPR screening, whether using knockout, activation, or inhibition approaches, has become an essential tool for drug discovery. A powerful adaptation of CRISPR screening is created by coupling pooled NGS-linked or arrayed screening strategies with phenotypic measurements. By using an advanced combination of techniques, this screening strategy can be targeted to detect genes that drive complex biological responses via biomarker signal readout or a panel of high content parameters. Scientists at Horizon, the sponsor of this LabTools webinar, have developed both FACS-linked and HCA-based strategies for analysis where cellular pathophysiology is uncoupled from cell health, providing much richer and biologically relevant outcomes. In this webinar, we will discuss data obtained and strategies learned from several successful screens and present ongoing work using increasingly relevant cell models, such as T cells and using single cell RNAseq-based screening approaches.

Topics to be Covered
  • Discussion of the strengths and considerations associated with complex phenotypic screens
  • Examples of successful applications of pooled and arrayed phenotypic screens
Tuesday, October 30, 2018
 
2:30 - 4:00 PM Eastern Time


Speakers

Andrew Brown.png
Benedict Cross, PhD
R&D Manager
Horizon Discovery

Andrew Brown.png
Carlos le Sage, PhD
Team Leader
Horizon Discovery

Andrew Brown.png
Steffen Lawo, PhD
Team Leader
Horizon Discovery


horizon all white.jpg

Register Now

TS_WEBINARSIGNUP_Phenotypic CRISPR Screening: Looking Beyond Cell Viability To Study Complex Genetic Interactions

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.